Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             132 results found
no title author magazine year volume issue page(s) type
1 A challenging case of catatonia during pregnancy Martinez-Sosa, Natalie

43-44 C p.
article
2 A cross-diagnostic study of adherence to ecological momentary assessment: Comparisons across study length and daily survey frequency find that early adherence is a potent predictor of study-long adherence Jones, Sara E.

43-44 C p.
article
3 Acute and six-month depression-related abnormalities in the sleep-wake rhythm of cardiac autonomic activity in survivors of acute coronary syndromes Castro, M.N.
2017
43-44 C p. 13-18
article
4 Acute antidepressant effects of deep brain stimulation – Review and data from slMFB-stimulation Bewernick, Bettina H.
2017
43-44 C p. 1-7
7 p.
article
5 Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial Furman, Jennifer L.
2018
43-44 C p. 1-7
article
6 An updated classification of antidepressants: A proposal to simplify treatment Alvano, Sebastian A.

43-44 C p.
article
7 An 8-week open label trial of l-Threonic Acid Magnesium Salt in patients with mild to moderate dementia Wroolie, Tonita E.
2017
43-44 C p. 7-12
article
8 Anxiolytic benefits of compounded Atenolol–Scopolamine in eight patients in psychiatry Benjamin, Ashley B.

43-44 C p.
article
9 Apathy and depression: Which clinical specificities? Batail, J.M.
2018
43-44 C p. 21-26
article
10 Are modern neuromodulation therapies too precise? McDonald, William M.

43-44 C p. 1-3
article
11 A review of transcranial direct current stimulation (tDCS) for the individualized treatment of depressive symptoms Jog, Mayank V.

43-44 C p. 17-22
article
12 A systematic review of treatments for misophonia Mattson, Seth A.

43-44 C p.
article
13 Autism presenting in the context of a genetic variant of CFTR and early HSV exposure confounded by chronic pain, altered gut microbiota and paternal abandonment; limitations of current pharmacotherapy and barriers to personalized treatment recommendations Deutsch, Stephen I.
2017
43-44 C p. 24-29
6 p.
article
14 Autoimmune disorders and postpartum psychosis: Case report with a comprehensive topical review Ganjekar, Sundarnag
2018
43-44 C p. 1-6
article
15 Baseline monitoring of atypical antipsychotics at a Family Medicine Teaching Unit (FMTU) in Ontario, Canada Ranpara, Manish

43-44 C p.
article
16 BDNF blood levels as a potential biomarker Predictor of treatment response and remission in bipolar depression Shkundin, Anton

43-44 C p.
article
17 Beyond antidepressant effects of deep brain stimulation – A systematic qualitative approach Ziesen, Nenja K.

43-44 C p.
article
18 Beyond one-size-fits-all: The rise of personalized treatment in schizophrenia Nashwan, Abdulqadir J.

43-44 C p.
article
19 Brain activation induced by psychological stress in nonpsychotic siblings of patients with schizophrenia Castro, M.N.
2017
43-44 C p. 74-80
7 p.
article
20 Brain-derived neurotrophic factor and stress perception Shkundin, Anton

43-44 C p.
article
21 Brain-derived neurotrophic factor (BDNF Val66Met) in borderline personality disorder: Associated with eating disorder comorbidity but not psychotherapy response Lisoway, Amanda

43-44 C p.
article
22 Can probiotics reduce bipolar symptoms?: A systematic review Ahmed, Nida

43-44 C p.
article
23 Characterizing chronic non-suicidal self-injury and other forms of repetitive and escalating suicide behaviour as endocannabinoid-mediated pain and reward disorders Kim, Hye Ji J.

43-44 C p.
article
24 Citalopram is less effective for patients with neurological disorder and/or post-traumatic stress disorder Alemi, Farrokh
2017
43-44 C p. 32-38
article
25 Clinical and psychosocial factors affecting outcome with sublingual buprenorphine-naloxone substitution in opioid dependence in terms of abstinence and compliance-A two years longitudinal study Das, Sourav

43-44 C p.
article
26 Clinical utility of pharmacogenetics-guided treatment of depression and anxiety Boland, Joseph R.
2018
43-44 C p. 7-13
article
27 Cognitive control circuit function predicts antidepressant outcomes: A signal detection approach to actionable clinical decisions Williams, Leanne M.

43-44 C p.
article
28 Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease Porter, Tenielle
2018
43-44 C p. 14-20
article
29 Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness Harvey, Philip D.

43-44 C p.
article
30 Correlation between duration of untreated psychosis and working memory in early-onset psychotic disorders Baskoro, Joko Cahyo

43-44 C p.
article
31 Cranial electrotherapy stimulation in the treatment of posttraumatic stress disorder: A feasibility, safety, and preliminary efficacy study Rustad, James K.

43-44 C p.
article
32 Currently available means to achieve personalized psychiatry Cohen, Bruce M.

43-44 C p.
article
33 CYP2D6 metabolizer status and HTTLPR variant of SLC6A4 associated with antidepressant-induced mania in bipolar disorder Beaupre, Lindsay Melhuish
2019
43-44 C p. 6-10
article
34 Deep brain stimulation for treatment-resistant depression: Predicting response and optimizing treatment Conroy, Susan K.

43-44 C p. 43-45
article
35 Defining irritability as a diagnostic marker and a target for responsiveness Bell, Erica

43-44 C p.
article
36 Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders Nuñez, Nicolas A

43-44 C p.
article
37 Depression as a systemic disease Sotelo, Jorge Luis
2017
43-44 C p. 11-25
15 p.
article
38 Differences in perceived life stress in bipolar I and II disorder: Implications for future epigenetic quantification Grzenda, Adrienne

43-44 C p.
article
39 Digital revolution in depression: A technologies update for clinicians Lazar, Max A.
2017
43-44 C p. 1-6
article
40 Disrupted copper homeostasis: Pathogenic factor in autism spectrum disorder and side effect of valproic acid Deutsch, Stephen I.

43-44 C p.
article
41 Diurnal variation of heart rate variability as a physiological index of mood and emotion regulation processes in Major Depression and Borderline Personality Disorder Wainsztein, Agustina E.

43-44 C p.
article
42 Does gender influence cognitive function in non-psychotic depression? Caldirola, Daniela
2017
43-44 C p. 25-31
article
43 Early treatment response affects signal detection in a placebo-controlled depression study Targum, Steven D.
2017
43-44 C p. 19-24
article
44 Effectiveness of stepped care for mental health disorders: An umbrella review of meta-analyses Jeitani, Anthony

43-44 C p.
article
45 Elucidation of molecular processes and biomarkers linked to the genetic variations driving the etiology of mood disorders Duc Nguyen, Hai

43-44 C p.
article
46 Erratum regarding missing ethical statements in previously published articles
43-44 C p.
article
47 Ethical implementation of precision psychiatry Ball, Tali M.

43-44 C p.
article
48 Expert opinion in Alzheimer disease: The silent scream of patients and their family during coronavirus disease 2019 (COVID-19) pandemic Guinjoan, Salvador M.

43-44 C p.
article
49 Expert opinion in anxiety disorder: Corona-phobia, the new face of anxiety Nardi, Antonio E.

43-44 C p.
article
50 Expert opinion in bipolar disorder: Impact of COVID-19 on outcomes and treatment of bipolar disorder Spelber, David

43-44 C p.
article
51 Expert opinion in mental disorder: Why is acceptance of the COVID-19 vaccines so problematic? Gorman, Jack M.

43-44 C p.
article
52 Expert opinion in Obsessive-Compulsive Disorder: Could protective measures for COVID-19 contribute to the worsening of OCD symptoms? Baldi, Samantha

43-44 C p.
article
53 Expert opinion in obsessive-compulsive disorder: Treating patients with obsessive-compulsive disorder during the COVID-19 pandemic Candelari, Abigail E.

43-44 C p.
article
54 Expert opinion in panic disorder: The impact of COVID-19-related fears, protective devices, and lockdown on panic and agoraphobia Caldirola, Daniela

43-44 C p.
article
55 Expert opinion in psychotherapy: The transformation of psychotherapy practice in the Covid-19 era Gabbard, Glen O.

43-44 C p.
article
56 Free testosterone is associated with perceived stress in women Flores-Ramos, Mónica

43-44 C p.
article
57 Gabapentin in the treatment of trichotillomania: A case report Yin, Katherine

43-44 C p.
article
58 Glutamate modulators for treatment of schizophrenia Zhand, Naista
2019
43-44 C p. 1-12
article
59 Glycogen synthase kinase3β: A key player of cognitive dysfunction in chronic kidney disease patients and a possible link between abnormal pTau and platelet APP processing and therapeutic role of erythropoietin Vinothkumar, G.

43-44 C p.
article
60 Health disparities in the treatment of bipolar disorder Tchikrizov, Vladimir

43-44 C p.
article
61 Identification of biotypes in Attention-Deficit/Hyperactivity Disorder, a report from a randomized, controlled trial Leikauf, John E.
2017
43-44 C p. 8-17
10 p.
article
62 Identification of clinical features and biomarkers that may inform a personalized approach to rTMS for depression Garnaat, Sarah L.

43-44 C p. 4-16
article
63 Impact of morbid obesity on treatment outcome in a clinical trial of major depressive disorder Targum, Steven D.
2017
43-44 C p. 18-23
6 p.
article
64 Impaired meaning-based cognitive skills are specifically associated with poorer subjective quality of life in schizophrenia Tan, Eric J.

43-44 C p.
article
65 Improvement of stuttering after administration of methylphenidate - a case report SheikhBahaei, Shahriar

43-44 C p.
article
66 Improving therapy outcome prediction in major depression using multimodal functional neuroimaging: A pilot study Schultz, Johannes
2018
43-44 C p. 7-15
article
67 Individual cognitive and depressive traits associated with maternal versus paternal family history of Late-onset Alzheimer’s disease: Proactive semantic interference versus standard neuropsychological assessments Wilson, Kathleen E.
2018
43-44 C p. 1-6
article
68 Individualized theta-burst stimulation modulates hippocampal activity and connectivity in patients with major depressive disorder Mielacher, Clemens

43-44 C p.
article
69 Integrated mental health and HIV care in a majority minority clinic Echenique, Marisa
2019
43-44 C p. 1-5
article
70 Integrating genetic variation with DNA methylation at SKA2 rs7208505 in analyses of obsessive-compulsive disorder disease risk and symptom severity Lisoway, Amanda J.

43-44 C p.
article
71 Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine Peters, Evyn M.
2018
43-44 C p. 27-30
article
72 Left versus right subcallosal cingulate deep brain stimulation for treatment-resistant depression Conroy, Susan K.

43-44 C p.
article
73 Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression Giampetruzzi, Eugenia

43-44 C p.
article
74 Low-dose lithium impact in an addiction treatment setting Gadh, Sudhir

43-44 C p.
article
75 Low dose pipamperone therapy for major depression: A randomized controlled clinical trial comparison with citalopram Buntinx, Erik

43-44 C p.
article
76 Low handgrip strength is a risk factor for symptoms of anxiety and depression in survivors breast cancer patients Oliveira, Mirella de P.L.

43-44 C p.
article
77 Magnetic seizure therapy: Towards personalized seizure therapy for major depression Kallioniemi, Elisa

43-44 C p. 37-42
article
78 Manic symptoms in the context of anti-thyroid antibodies and letrozole infertility treatment Dlugolecki, Leah M.
2019
43-44 C p. 19-21
article
79 Measurement invariance of the Childhood Trauma Questionnaire by gender, poverty level, and HIV status Rodriguez, Violeta J.
2018
43-44 C p. 16-22
article
80 Measurement invariance of the Screen for Child Anxiety Related Emotional Disorders (SCARED) across ethnicity, age, and sex among youth with depression Silva, Ticiane

43-44 C p.
article
81 Mediating effect of emotional distress on the relationship between noncommunicable diseases and lifestyle among Brazilian academics during the COVID-19 pandemic Rafael Pena, Siqueira

43-44 C p.
article
82 Mental health of young researchers in academia: Towards to growth perspective Di Giacomo, Dina

43-44 C p.
article
83 Monosodium glutamate influences depressive behavior of two age groups of mice in forced swimming test: Vitamin B6 could remedy the situation Mesripour, Azadeh
2019
43-44 C p. 28-32
article
84 Multimodal phenotyping of psychiatric disorders from social interaction: Protocol of a clinical multicenter prospective study König, Alexandra

43-44 C p.
article
85 Neurocognitive impairment in patients with comorbid diabetes mellitus and depression Padilla, Vanessa L.
2017
43-44 C p. 2-10
9 p.
article
86 Open-label pilot study of psychiatric pharmacogenetic testing in an adult psychiatric inpatient population King, Christopher D.

43-44 C p.
article
87 Options when anti-depressants cannot be used in conventional ways. Clinical case and review of literature Das, Aparna
2019
43-44 C p. 22-27
article
88 Outside the typical anxiety disorder definition: Characterizing the role of impulsivity in comorbid substance use disorder Tomasi, Julia
2019
43-44 C p. 13-21
article
89 Peripheral kynurenines as biomarkers and targets for prevention and treatment of psychiatric conditions associated with SARS-CoV-2 infection Oxenkrug, Gregory

43-44 C p.
article
90 Perphenazine-induced sialorrhea successfully treated with sublingual atropine: A case report Lee, Heather Fiona
2019
43-44 C p. 22-24
article
91 Personalized definition of surgical targets in major depression and obsessive-compulsive disorder: A potential role for low-intensity focused ultrasound? Guinjoan, Salvador M.

43-44 C p.
article
92 Personalized functional connectivity analysis in responders and nonresponders to ketamine and electroconvulsive therapy: A case series Fazzito, Maria Lucia

43-44 C p.
article
93 Personalized medicine in panic disorder: where are we now? A meta-regression analysis Caldirola, Daniela
2017
43-44 C p. 26-38
13 p.
article
94 Personalized Medicine in Psychiatry: Back to the Future Perna, Giampaolo
2017
43-44 C p. 1-
1 p.
article
95 Personalizing antidepressant choice by sex, body mass index, and symptom profile: An iSPOT-D report Green, Erin
2017
43-44 C p. 65-73
9 p.
article
96 Precision ECT for major depressive disorder: A review of clinical factors, laboratory, and physiologic biomarkers as predictors of response and remission Yao, Zhixing

43-44 C p. 23-31
article
97 Predicting subjective quality of life and illness impact for individuals with schizophrenia using the Five-Factor Model of personality: A starting point for future research Rogers, Russell T.

43-44 C p.
article
98 Predictors of response for vagus nerve stimulation in treatment-resistant depression de Leon, V.C.

43-44 C p. 32-36
article
99 Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression Peters, Evyn M.

43-44 C p.
article
100 Preliminary insights into the genetic architecture of postpartum depressive symptom severity using polygenic risk scores Pouget, Jennie G.

43-44 C p.
article
101 Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery Stone, Jordan

43-44 C p.
article
102 Publisher Note
43-44 C p.
article
103 Putative biological predictors of treatment response in bipolar disorders Gonzalez, Suzanne D.
2017
43-44 C p. 39-58
20 p.
article
104 Putative novel neuromodulatory treatments for affective disorders – What might emerge? Kilian, Hannah M.

43-44 C p. 46-50
article
105 Qualitative treatment-subgroup interactions in the antidepressant treatment of major depression: Application of QUINT to individual participant data from seven placebo-controlled randomized controlled trials Maruo, Kazushi

43-44 C p.
article
106 Quetiapine-induced peripheral oedema: A case report and review of the literature Geldenhuys, Christoff

43-44 C p.
article
107 Randomized, Placebo-controlled, Antidepressant Treatment of Patients with Major Depressive Disorder: Changes in Glomerular Filtration Rate Claros-Erazo, Melissa

43-44 C p.
article
108 Repetitive negative thinking is associated with impaired verbal learning but not executive functioning in individuals with eating disorders Cardenas, Grace E.

43-44 C p.
article
109 SCL6A4 polymorphisms rs25533 and I425V: Association with obsessive–compulsive disorder and its treatment response in Iranian patients Ahmadipour, Ehsan
2018
43-44 C p. 23-29
article
110 Special issue editorial: Personalized medicine in psychiatry in the COVID-19 era: Fighting the impact of the pandemic on mental health Perna, Giampaolo

43-44 C p.
article
111 Subjective impact of COVID-19 pandemic on youth with tic and OCD spectrum disorders Tomczak, Kinga K.

43-44 C p.
article
112 Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment Ward, Heather Burrell

43-44 C p.
article
113 Superolateral medial forebrain bundle deep brain stimulation for obsessive-compulsive disorder in both spouses of a married couple – Couple case report Czornik, Manuel

43-44 C p.
article
114 Symptom provocation to enhance the treatment effect of transcranial magnetic stimulation for obsessive compulsive disorder—A systematic review, evaluation and discussion Liu, Lucia B.

43-44 C p.
article
115 T3 augmentation in major depressive disorder: Sex and age differences Hajnas, Natalia

43-44 C p.
article
116 Ten-year patterns of psychiatric medications dispensed to adolescent in Finland: Open dialogue-informed practice in Western Lapland as compared to practice in other Finnish regions Valtanen, Kari

43-44 C p.
article
117 The depression and anxiety status and influencing factors survey of international students during COVID-19 outbreak period in Hunan, China: A cross-sectional study Conteh, Ishmail

43-44 C p.
article
118 The multi-modal treatment of catatonia: Targeting multiple receptors when GABA-based benzodiazepines fail Veluri, Nikhila

43-44 C p.
article
119 The narrative crisis model of suicide: A review of empirical evidence for an innovative dynamic model of suicide and a comparison with other theoretical frameworks Bloch-Elkouby, Sarah

43-44 C p.
article
120 The narrative crisis model of suicide as a framework for suicide prevention Rogers, Megan L.

43-44 C p.
article
121 The relationship between circadian gene single nucleotide polymorphisms and clinical and behavioral assessments of sleep and rhythms and course of illness characteristics in subjects with bipolar type I disorder Gonzalez, Robert
2019
43-44 C p. 11-18
article
122 The structure of personality disorders within a depressed sample: Implications for personalizing treatment Berg, Joanna M.
2017
43-44 C p. 59-64
6 p.
article
123 The temporal dynamics of daily stress, affect, and several affect regulation processes, in patients with chronic mood and anxiety disorders before and after a mindful yoga intervention Vollbehr, Nina K.

43-44 C p.
article
124 The Texas child mental health network: A child and adolescent research registry Tamminga, Carol A.

43-44 C p.
article
125 The United States index of socioeconomic deprivation for individuals (USiDep) Dunlop, Boadie W.

43-44 C p.
article
126 The use of dextroamphetamine/amphetamine to treat attention-deficit/hyperactivity disorder comorbid with borderline personality disorder: A case report Ellenberg, Stacy

43-44 C p.
article
127 The use of machine learning and deep learning models in detecting depression on social media: A systematic literature review Gadzama, Wadzani Aduwamai

43-44 C p.
article
128 Trajectory modeling and response prediction in transcranial magnetic stimulation for depression McInnes, Aaron N.

43-44 C p.
article
129 Using empathy to prevent burnout treating patients with cluster B personality disorders in psychiatry residency: A case study in context Derrick Knox, LT

43-44 C p.
article
130 Utilizing a transdiagnostic neuroscience-informed approach to differentiate the components of a complex clinical presentation: A case report Vanden Bussche, Alicia B.
2017
43-44 C p. 30-37
8 p.
article
131 Withdrawal symptoms after discontinuation of a noradrenergic and specific serotonergic antidepressant: A case report and review of the literature Cosci, Fiammetta
2017
43-44 C p. 81-84
4 p.
article
132 Ziconotide-induced psychosis in patient without previous psychiatric history: A case report Su, Amanda

43-44 C p.
article
                             132 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands